- Home
- EHAB vs DIAX Comparison
EHAB vs DIAX Comparison
Compare EHAB & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- DIAX
- Stock Information
- Founded
- EHAB 2014
- DIAX 2005
- Country
- EHAB United States
- DIAX United States
- Employees
- EHAB N/A
- DIAX N/A
- Industry
- EHAB Hospital/Nursing Management
- DIAX Finance Companies
- Sector
- EHAB Health Care
- DIAX Finance
- Exchange
- EHAB Nasdaq
- DIAX Nasdaq
- Market Cap
- EHAB 401.6M
- DIAX 477.5M
- IPO Year
- EHAB N/A
- DIAX N/A
- Fundamental
- Price
- EHAB $10.26
- DIAX $14.01
- Analyst Decision
- EHAB Hold
- DIAX
- Analyst Count
- EHAB 3
- DIAX 0
- Target Price
- EHAB $8.50
- DIAX N/A
- AVG Volume (30 Days)
- EHAB 319.6K
- DIAX 96.6K
- Earning Date
- EHAB 05-07-2025
- DIAX 01-01-0001
- Dividend Yield
- EHAB N/A
- DIAX 7.93%
- EPS Growth
- EHAB N/A
- DIAX N/A
- EPS
- EHAB N/A
- DIAX N/A
- Revenue
- EHAB $1,032,300,000.00
- DIAX N/A
- Revenue This Year
- EHAB $5.33
- DIAX N/A
- Revenue Next Year
- EHAB $4.86
- DIAX N/A
- P/E Ratio
- EHAB N/A
- DIAX N/A
- Revenue Growth
- EHAB N/A
- DIAX N/A
- 52 Week Low
- EHAB $6.85
- DIAX $12.80
- 52 Week High
- EHAB $10.70
- DIAX $15.12
- Technical
- Relative Strength Index (RSI)
- EHAB 79.60
- DIAX 52.21
- Support Level
- EHAB $7.89
- DIAX $13.88
- Resistance Level
- EHAB $8.12
- DIAX $14.17
- Average True Range (ATR)
- EHAB 0.32
- DIAX 0.16
- MACD
- EHAB 0.27
- DIAX 0.07
- Stochastic Oscillator
- EHAB 97.46
- DIAX 83.33
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.